Report Cover

Global Bicalutamide Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    Tablets
    Capsule

Segment by Application
    Single Drug For Prostate Cancer
    Combined Chemotherapy For Prostate Cancer
    Combined Radiation Therapy Or Castration For Prostate Cancer

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    AstraZeneca
    CORDEN PHARMA GMBH
    Zeneca GmbH
    Actavis Pharma
    Sivem Pharmaceuticals
    Sorres Pharma
    Fresenius Kabi
    ANI Pharmaceuticals
    Accel Pharma
    Apotex Corporation
    Shanghai Fudan Fuhua Pharmaceutical
    Shanghai Zhaohui Pharmaceutical
    Zhejiang Haizheng Pharmaceutical
    Shanxi Zhendong Pharmaceutical
1 Bicalutamide Market Overview
    1.1 Product Overview and Scope of Bicalutamide
    1.2 Bicalutamide Segment by Type
        1.2.1 Global Bicalutamide Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Tablets
        1.2.3 Capsule
    1.3 Bicalutamide Segment by Application
        1.3.1 Bicalutamide Sales Comparison by Application: (2021-2027)
        1.3.2 Single Drug For Prostate Cancer
        1.3.3 Combined Chemotherapy For Prostate Cancer
        1.3.4 Combined Radiation Therapy Or Castration For Prostate Cancer
    1.4 Global Bicalutamide Market Size Estimates and Forecasts
        1.4.1 Global Bicalutamide Revenue 2016-2027
        1.4.2 Global Bicalutamide Sales 2016-2027
        1.4.3 Bicalutamide Market Size by Region: 2016 Versus 2021 Versus 2027

2 Bicalutamide Market Competition by Manufacturers
    2.1 Global Bicalutamide Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Bicalutamide Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Bicalutamide Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Bicalutamide Manufacturing Sites, Area Served, Product Type
    2.5 Bicalutamide Market Competitive Situation and Trends
        2.5.1 Bicalutamide Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Bicalutamide Players Market Share by Revenue
        2.5.3 Global Bicalutamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Bicalutamide Retrospective Market Scenario by Region
    3.1 Global Bicalutamide Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Bicalutamide Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Bicalutamide Market Facts & Figures by Country
        3.3.1 North America Bicalutamide Sales by Country
        3.3.2 North America Bicalutamide Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Bicalutamide Market Facts & Figures by Country
        3.4.1 Europe Bicalutamide Sales by Country
        3.4.2 Europe Bicalutamide Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Bicalutamide Market Facts & Figures by Region
        3.5.1 Asia Pacific Bicalutamide Sales by Region
        3.5.2 Asia Pacific Bicalutamide Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Bicalutamide Market Facts & Figures by Country
        3.6.1 Latin America Bicalutamide Sales by Country
        3.6.2 Latin America Bicalutamide Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Bicalutamide Market Facts & Figures by Country
        3.7.1 Middle East and Africa Bicalutamide Sales by Country
        3.7.2 Middle East and Africa Bicalutamide Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Bicalutamide Historic Market Analysis by Type
    4.1 Global Bicalutamide Sales Market Share by Type (2016-2021)
    4.2 Global Bicalutamide Revenue Market Share by Type (2016-2021)
    4.3 Global Bicalutamide Price by Type (2016-2021)

5 Global Bicalutamide Historic Market Analysis by Application
    5.1 Global Bicalutamide Sales Market Share by Application (2016-2021)
    5.2 Global Bicalutamide Revenue Market Share by Application (2016-2021)
    5.3 Global Bicalutamide Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 AstraZeneca
        6.1.1 AstraZeneca Corporation Information
        6.1.2 AstraZeneca Description and Business Overview
        6.1.3 AstraZeneca Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 AstraZeneca Product Portfolio
        6.1.5 AstraZeneca Recent Developments/Updates
    6.2 CORDEN PHARMA GMBH
        6.2.1 CORDEN PHARMA GMBH Corporation Information
        6.2.2 CORDEN PHARMA GMBH Description and Business Overview
        6.2.3 CORDEN PHARMA GMBH Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 CORDEN PHARMA GMBH Product Portfolio
        6.2.5 CORDEN PHARMA GMBH Recent Developments/Updates
    6.3 Zeneca GmbH
        6.3.1 Zeneca GmbH Corporation Information
        6.3.2 Zeneca GmbH Description and Business Overview
        6.3.3 Zeneca GmbH Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Zeneca GmbH Product Portfolio
        6.3.5 Zeneca GmbH Recent Developments/Updates
    6.4 Actavis Pharma
        6.4.1 Actavis Pharma Corporation Information
        6.4.2 Actavis Pharma Description and Business Overview
        6.4.3 Actavis Pharma Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Actavis Pharma Product Portfolio
        6.4.5 Actavis Pharma Recent Developments/Updates
    6.5 Sivem Pharmaceuticals
        6.5.1 Sivem Pharmaceuticals Corporation Information
        6.5.2 Sivem Pharmaceuticals Description and Business Overview
        6.5.3 Sivem Pharmaceuticals Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Sivem Pharmaceuticals Product Portfolio
        6.5.5 Sivem Pharmaceuticals Recent Developments/Updates
    6.6 Sorres Pharma
        6.6.1 Sorres Pharma Corporation Information
        6.6.2 Sorres Pharma Description and Business Overview
        6.6.3 Sorres Pharma Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Sorres Pharma Product Portfolio
        6.6.5 Sorres Pharma Recent Developments/Updates
    6.7 Fresenius Kabi
        6.6.1 Fresenius Kabi Corporation Information
        6.6.2 Fresenius Kabi Description and Business Overview
        6.6.3 Fresenius Kabi Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Fresenius Kabi Product Portfolio
        6.7.5 Fresenius Kabi Recent Developments/Updates
    6.8 ANI Pharmaceuticals
        6.8.1 ANI Pharmaceuticals Corporation Information
        6.8.2 ANI Pharmaceuticals Description and Business Overview
        6.8.3 ANI Pharmaceuticals Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 ANI Pharmaceuticals Product Portfolio
        6.8.5 ANI Pharmaceuticals Recent Developments/Updates
    6.9 Accel Pharma
        6.9.1 Accel Pharma Corporation Information
        6.9.2 Accel Pharma Description and Business Overview
        6.9.3 Accel Pharma Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Accel Pharma Product Portfolio
        6.9.5 Accel Pharma Recent Developments/Updates
    6.10 Apotex Corporation
        6.10.1 Apotex Corporation Corporation Information
        6.10.2 Apotex Corporation Description and Business Overview
        6.10.3 Apotex Corporation Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Apotex Corporation Product Portfolio
        6.10.5 Apotex Corporation Recent Developments/Updates
    6.11 Shanghai Fudan Fuhua Pharmaceutical
        6.11.1 Shanghai Fudan Fuhua Pharmaceutical Corporation Information
        6.11.2 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Description and Business Overview
        6.11.3 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Shanghai Fudan Fuhua Pharmaceutical Product Portfolio
        6.11.5 Shanghai Fudan Fuhua Pharmaceutical Recent Developments/Updates
    6.12 Shanghai Zhaohui Pharmaceutical
        6.12.1 Shanghai Zhaohui Pharmaceutical Corporation Information
        6.12.2 Shanghai Zhaohui Pharmaceutical Bicalutamide Description and Business Overview
        6.12.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Shanghai Zhaohui Pharmaceutical Product Portfolio
        6.12.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
    6.13 Zhejiang Haizheng Pharmaceutical
        6.13.1 Zhejiang Haizheng Pharmaceutical Corporation Information
        6.13.2 Zhejiang Haizheng Pharmaceutical Bicalutamide Description and Business Overview
        6.13.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Zhejiang Haizheng Pharmaceutical Product Portfolio
        6.13.5 Zhejiang Haizheng Pharmaceutical Recent Developments/Updates
    6.14 Shanxi Zhendong Pharmaceutical
        6.14.1 Shanxi Zhendong Pharmaceutical Corporation Information
        6.14.2 Shanxi Zhendong Pharmaceutical Bicalutamide Description and Business Overview
        6.14.3 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Shanxi Zhendong Pharmaceutical Product Portfolio
        6.14.5 Shanxi Zhendong Pharmaceutical Recent Developments/Updates

7 Bicalutamide Manufacturing Cost Analysis
    7.1 Bicalutamide Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Bicalutamide
    7.4 Bicalutamide Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Bicalutamide Distributors List
    8.3 Bicalutamide Customers

9 Bicalutamide Market Dynamics
    9.1 Bicalutamide Industry Trends
    9.2 Bicalutamide Growth Drivers
    9.3 Bicalutamide Market Challenges
    9.4 Bicalutamide Market Restraints

10 Global Market Forecast
    10.1 Bicalutamide Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Bicalutamide by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Bicalutamide by Type (2022-2027)
    10.2 Bicalutamide Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Bicalutamide by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Bicalutamide by Application (2022-2027)
    10.3 Bicalutamide Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Bicalutamide by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Bicalutamide by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Bicalutamide Sales (M Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global Bicalutamide Sales (M Pcs) Comparison by Application (2021-2027) Table 3. Global Bicalutamide Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Bicalutamide Covered in This Study Table 5. Global Bicalutamide Sales (M Pcs) of Key Manufacturers (2016-2021) Table 6. Global Bicalutamide Sales Share by Manufacturers (2016-2021) Table 7. Global Bicalutamide Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Bicalutamide Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Bicalutamide Average Price (US$/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers Bicalutamide Manufacturing Sites and Area Served Table 11. Manufacturers Bicalutamide Product Type Table 12. Global Bicalutamide Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Bicalutamide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bicalutamide as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Bicalutamide Sales by Region (2016-2021) & (M Pcs) Table 16. Global Bicalutamide Sales Market Share by Region (2016-2021) Table 17. Global Bicalutamide Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Bicalutamide Sales by Country (2016-2021) & (M Pcs) Table 19. North America Bicalutamide Sales Market Share by Country (2016-2021) Table 20. North America Bicalutamide Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Bicalutamide Revenue Market Share by Country (2016-2021) Table 22. Europe Bicalutamide Sales by Country (2016-2021) & (M Pcs) Table 23. Europe Bicalutamide Sales Market Share by Country (2016-2021) Table 24. Europe Bicalutamide Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Bicalutamide Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Bicalutamide Sales by Region (2016-2021) & (M Pcs) Table 27. Asia Pacific Bicalutamide Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Bicalutamide Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Bicalutamide Revenue Market Share by Region (2016-2021) Table 30. Latin America Bicalutamide Sales by Country (2016-2021) & (M Pcs) Table 31. Latin America Bicalutamide Sales Market Share by Country (2016-2021) Table 32. Latin America Bicalutamide Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Bicalutamide Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Bicalutamide Sales by Country (2016-2021) & (M Pcs) Table 35. Middle East and Africa Bicalutamide Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Bicalutamide Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Bicalutamide Revenue Market Share by Country (2016-2021) Table 38. Global Bicalutamide Sales (M Pcs) by Type (2016-2021) Table 39. Global Bicalutamide Sales Market Share by Type (2016-2021) Table 40. Global Bicalutamide Revenue (Million US$) by Type (2016-2021) Table 41. Global Bicalutamide Revenue Share by Type (2016-2021) Table 42. Global Bicalutamide Price (US$/Pcs) by Type (2016-2021) Table 43. Global Bicalutamide Sales (M Pcs) by Application (2016-2021) Table 44. Global Bicalutamide Sales Market Share by Application (2016-2021) Table 45. Global Bicalutamide Revenue (Million US$) by Application (2016-2021) Table 46. Global Bicalutamide Revenue Share by Application (2016-2021) Table 47. Global Bicalutamide Price (US$/Pcs) by Application (2016-2021) Table 48. AstraZeneca Corporation Information Table 49. AstraZeneca Description and Business Overview Table 50. AstraZeneca Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 51. AstraZeneca Bicalutamide Product Table 52. AstraZeneca Recent Developments/Updates Table 53. CORDEN PHARMA GMBH Corporation Information Table 54. CORDEN PHARMA GMBH Description and Business Overview Table 55. CORDEN PHARMA GMBH Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 56. CORDEN PHARMA GMBH Bicalutamide Product Table 57. CORDEN PHARMA GMBH Recent Developments/Updates Table 58. Zeneca GmbH Corporation Information Table 59. Zeneca GmbH Description and Business Overview Table 60. Zeneca GmbH Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 61. Zeneca GmbH Bicalutamide Product Table 62. Zeneca GmbH Recent Developments/Updates Table 63. Actavis Pharma Corporation Information Table 64. Actavis Pharma Description and Business Overview Table 65. Actavis Pharma Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 66. Actavis Pharma Bicalutamide Product Table 67. Actavis Pharma Recent Developments/Updates Table 68. Sivem Pharmaceuticals Corporation Information Table 69. Sivem Pharmaceuticals Description and Business Overview Table 70. Sivem Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 71. Sivem Pharmaceuticals Bicalutamide Product Table 72. Sivem Pharmaceuticals Recent Developments/Updates Table 73. Sorres Pharma Corporation Information Table 74. Sorres Pharma Description and Business Overview Table 75. Sorres Pharma Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 76. Sorres Pharma Bicalutamide Product Table 77. Sorres Pharma Recent Developments/Updates Table 78. Fresenius Kabi Corporation Information Table 79. Fresenius Kabi Description and Business Overview Table 80. Fresenius Kabi Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 81. Fresenius Kabi Bicalutamide Product Table 82. Fresenius Kabi Recent Developments/Updates Table 83. ANI Pharmaceuticals Corporation Information Table 84. ANI Pharmaceuticals Description and Business Overview Table 85. ANI Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 86. ANI Pharmaceuticals Bicalutamide Product Table 87. ANI Pharmaceuticals Recent Developments/Updates Table 88. Accel Pharma Corporation Information Table 89. Accel Pharma Description and Business Overview Table 90. Accel Pharma Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 91. Accel Pharma Bicalutamide Product Table 92. Accel Pharma Recent Developments/Updates Table 93. Apotex Corporation Corporation Information Table 94. Apotex Corporation Description and Business Overview Table 95. Apotex Corporation Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 96. Apotex Corporation Bicalutamide Product Table 97. Apotex Corporation Recent Developments/Updates Table 98. Shanghai Fudan Fuhua Pharmaceutical Corporation Information Table 99. Shanghai Fudan Fuhua Pharmaceutical Description and Business Overview Table 100. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 101. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product Table 102. Shanghai Fudan Fuhua Pharmaceutical Recent Developments/Updates Table 103. Shanghai Zhaohui Pharmaceutical Corporation Information Table 104. Shanghai Zhaohui Pharmaceutical Description and Business Overview Table 105. Shanghai Zhaohui Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 106. Shanghai Zhaohui Pharmaceutical Bicalutamide Product Table 107. Shanghai Zhaohui Pharmaceutical Recent Developments/Updates Table 108. Zhejiang Haizheng Pharmaceutical Corporation Information Table 109. Zhejiang Haizheng Pharmaceutical Description and Business Overview Table 110. Zhejiang Haizheng Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 111. Zhejiang Haizheng Pharmaceutical Bicalutamide Product Table 112. Zhejiang Haizheng Pharmaceutical Recent Developments/Updates Table 113. Shanxi Zhendong Pharmaceutical Corporation Information Table 114. Shanxi Zhendong Pharmaceutical Description and Business Overview Table 115. Shanxi Zhendong Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 116. Shanxi Zhendong Pharmaceutical Bicalutamide Product Table 117. Shanxi Zhendong Pharmaceutical Recent Developments/Updates Table 118. Production Base and Market Concentration Rate of Raw Material Table 119. Key Suppliers of Raw Materials Table 120. Bicalutamide Distributors List Table 121. Bicalutamide Customers List Table 122. Bicalutamide Market Trends Table 123. Bicalutamide Growth Drivers Table 124. Bicalutamide Market Restraints Table 125. Global Bicalutamide Sales Forecast by Type (2022-2027) & (M Pcs) Table 126. Global Bicalutamide Sales Market Share Forecast by Type (2022-2027) Table 127. Global Bicalutamide Revenue Forecast by Type (2022-2027) & (US$ Million) Table 128. Global Bicalutamide Revenue Market Share Forecast by Type (2022-2027) Table 129. Global Bicalutamide Sales Forecast by Application (2022-2027) & (M Pcs) Table 130. Global Bicalutamide Sales Market Share Forecast by Application (2022-2027) Table 131. Global Bicalutamide Revenue Forecast by Application (2022-2027) & (US$ Million) Table 132. Global Bicalutamide Revenue Market Share Forecast by Application (2022-2027) Table 133. Global Bicalutamide Sales Forecast by Region (2022-2027) & (M Pcs) Table 134. Global Bicalutamide Sales Market Share Forecast by Region (2022-2027) Table 135. Global Bicalutamide Revenue Forecast by Region (2022-2027) & (US$ Million) Table 136. Global Bicalutamide Revenue Market Share Forecast by Region (2022-2027) Table 137. Research Programs/Design for This Report Table 138. Key Data Information from Secondary Sources Table 139. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Bicalutamide Figure 2. Global Bicalutamide Market Share by Type in 2020 & 2027 Figure 3. Tablets Product Picture Figure 4. Capsule Product Picture Figure 5. Global Bicalutamide Market Share by Application in 2020 & 2027 Figure 6. Single Drug For Prostate Cancer Figure 7. Combined Chemotherapy For Prostate Cancer Figure 8. Combined Radiation Therapy Or Castration For Prostate Cancer Figure 9. Global Bicalutamide Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Bicalutamide Market Size 2016-2027 (US$ Million) Figure 11. Global Bicalutamide Sales 2016-2027 (M Pcs) Figure 12. Global Bicalutamide Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Bicalutamide Sales Share by Manufacturers in 2020 Figure 14. Global Bicalutamide Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Bicalutamide Players: Market Share by Revenue in 2020 Figure 16. Bicalutamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Bicalutamide Sales Market Share by Region (2016-2021) Figure 18. Global Bicalutamide Sales Market Share by Region in 2020 Figure 19. Global Bicalutamide Revenue Market Share by Region (2016-2021) Figure 20. Global Bicalutamide Revenue Market Share by Region in 2020 Figure 21. U.S. Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. UAE Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Bicalutamide by Type (2016-2021) Figure 46. Sales Market Share of Bicalutamide by Application (2016-2021) Figure 47. Sales Market Share of Bicalutamide by Application in 2020 Figure 48. Revenue Share of Bicalutamide by Application (2016-2021) Figure 49. Revenue Share of Bicalutamide by Application in 2020 Figure 50. Manufacturing Cost Structure of Bicalutamide Figure 51. Manufacturing Process Analysis of Bicalutamide Figure 52. Bicalutamide Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us